Search research articles
Contact Us
Filters
Showing results (191-200 of 306) with videos related to
Page
of 31
Sort By:
Lancet (London, England)
|
July 25, 1987
RU 486 administration in a child with Cushing's syndrome
B Beaufrère, L de Parscau, P Chatelain, et al.
Annales De Pathologie
|
January 1, 1990
[Eosinophilic myocarditis and pulmonary hypertension in a drug-addict. Anatomo-clinical study and brief review of the literature]
V C Talebzadeh, J C Chevrolet, P Chatelain, et al.
Molecular Pharmacology
|
May 1, 1982
Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy
P Robberecht, M Waelbroeck, M Claeys, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 1, 1983
Selective alteration of secretin-stimulated cardiac adenylate cyclase activity in streptozotocin-diabetic rats
P Chatelain, L Gillet, M Waelbroeck, et al.
Hormone Research
|
January 1, 1990
Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset of growth failure
J C Job, P Chatelain, P Rochiccioli, et al.
Proceedings. IEEE International Symposium on Biomedical Imaging
|
June 4, 2020
Discovering Salient Anatomical Landmarks by Predicting Human Gaze
R Droste, P Chatelain, L Drukker, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
April 2, 1999
Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board
W Cutfield, A Lindberg, K Albertsson Wikland, et al.
Trends in Endocrinology and Metabolism: TEM
|
April 15, 2008
Growth hormone treatment of short children born small for gestational age
F de Zegher, I Francois, M van Helvoirt, et al.
Circulation
|
May 1, 1987
Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion
P Chatelain, J G Latour, D Tran, et al.
Pediatrie
|
January 1, 1989
[Hypothalamic dysfunction. 2 cases: the contribution of nuclear magnetic resonance, therapeutic trial of naltrexone]
G A Loeuille, L de Parscau, H Ythier, et al.
Page
of 31
Search research articles
Search
Showing results (191-200 of 306) with videos related to
Sort By:
Page
of 31
Lancet (London, England)
|
July 25, 1987
RU 486 administration in a child with Cushing's syndrome
B Beaufrère, L de Parscau, P Chatelain, et al.
Annales De Pathologie
|
January 1, 1990
[Eosinophilic myocarditis and pulmonary hypertension in a drug-addict. Anatomo-clinical study and brief review of the literature]
V C Talebzadeh, J C Chevrolet, P Chatelain, et al.
Molecular Pharmacology
|
May 1, 1982
Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy
P Robberecht, M Waelbroeck, M Claeys, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 1, 1983
Selective alteration of secretin-stimulated cardiac adenylate cyclase activity in streptozotocin-diabetic rats
P Chatelain, L Gillet, M Waelbroeck, et al.
Hormone Research
|
January 1, 1990
Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset of growth failure
J C Job, P Chatelain, P Rochiccioli, et al.
Proceedings. IEEE International Symposium on Biomedical Imaging
|
June 4, 2020
Discovering Salient Anatomical Landmarks by Predicting Human Gaze
R Droste, P Chatelain, L Drukker, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
April 2, 1999
Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board
W Cutfield, A Lindberg, K Albertsson Wikland, et al.
Trends in Endocrinology and Metabolism: TEM
|
April 15, 2008
Growth hormone treatment of short children born small for gestational age
F de Zegher, I Francois, M van Helvoirt, et al.
Circulation
|
May 1, 1987
Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion
P Chatelain, J G Latour, D Tran, et al.
Pediatrie
|
January 1, 1989
[Hypothalamic dysfunction. 2 cases: the contribution of nuclear magnetic resonance, therapeutic trial of naltrexone]
G A Loeuille, L de Parscau, H Ythier, et al.
Page
of 31